Inventor
HORVATH STEPHANE
FR20 patents
Patents
20 patentsUS7176197B2Feb 13, 2007
Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB17 citations91
US7250531B2Jul 31, 2007
Process for the synthesis and crystalline form of agomelatine
SERVIER LAB17 citations90
US7384932B2Jun 10, 2008
δd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB11 citations83
US7361650B2Apr 22, 2008
γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB11 citations83
US7361649B2Apr 22, 2008
β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB9 citations83
US7498466B2Mar 3, 2009
Process for the synthesis and crystalline form of agomelatine
SERVIER LAB8 citations82
US7361652B2Apr 22, 2008
βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB6 citations73
US7358240B2Apr 15, 2008
δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB6 citations73
US7544839B2Jun 9, 2009
Process for the synthesis and crystalline form agomelatine
SERVIER LAB7 citations71
US7879842B2Feb 1, 2011
Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB4 citations62
US7872001B2Jan 18, 2011
Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB2 citations62
US7867997B2Jan 11, 2011
δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB3 citations62
US7867996B2Jan 11, 2011
γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB3 citations62
US7361651B2Apr 22, 2008
γd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB5 citations62
US7867994B2Jan 11, 2011
Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB3 citations61
US7745482B2Jun 29, 2010
Alpha crystalline form of strontium ranelate
SERVIER LAB1 citations59
US7459568B2Dec 2, 2008
Alpha crystalline form of strontium ranelate
SERVIER LAB3 citations59
US7879841B2Feb 1, 2011
Delta D-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB0 citations51
US7867995B2Jan 11, 2011
βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SERVIER LAB0 citations51
US7498465B2Mar 3, 2009
Process for the synthesis and crystalline form of agomelatine
SERVIER LAB1 citations49